Just some thoughts from my end....

Makes sense IMO.  What would't make sense is the Eversana paragraph (below) in the news release, and then they pull the rug?

....“We’re pleased to support this important evolution of apabetalone and Resverlogix in its Phase 3 CORAL study,” said Kevin McDermott, Resverlogix Chief Commercial Officer, EVERSANA. “The EVERSANA COMPLETE Commercialization model is built to support customer needs by offering flexibility to quickly adapt development and launch strategies to meet market demands.”